Chicago, October 18-22, 2023 – This year, researchers from the ReCoDID project participated at the American Society of Tropical Medicine and Hygiene (ASTMH) conference in Chicago, presenting findings on Zika Virus (ZIKV) birth cohort studies during the 2015-18 epidemic.
At the forefront of the symposium was the exploration of ZIKV birth cohort studies, where members from the ReCoDID team assessed risks and outcomes associated with maternal ZIKV infection during pregnancy. In a world anticipating the emergence of vaccines and antibodies, the researchers’ mission was clear: consolidate insights, bridge gaps, and prepare for potential re-emergence.
The symposium showcased a deep dive into the complexities of maternal ZIKV infection and its profound impact on birth outcomes. With vaccines on the horizon, the team is strategically leveraging natural history cohorts to solidify evidence, contributing crucial knowledge to the ongoing global efforts in combating infectious diseases.
In addition to the symposium, a compelling poster presentation drew attention. A ReCoDID researcher delved into ZIKV policies during the 2015-18 epidemic, shedding light on the varied responses from multiple countries included in the ZIKAlliance. The study examined the challenges of diagnosis, ultrasound screening schedules, and the critical issue of pregnancy termination policies during the epidemic. The findings underscored the disparities in responses, emphasizing the pivotal role of guidelines in shaping effective public health interventions. The study revealed that during the ZIKV epidemic, disparities existed not only in diagnostic practices but also in the approaches to pregnancy termination policies, indicating the need for a comprehensive and uniform response strategy.
The ReCoDID team’s presence at ASTMH 2023 exemplifies their commitment to advancing the understanding of infectious diseases, fostering collaboration, and contributing to global efforts in safeguarding public health.